Innovation Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch IPIX and buy or sell other stocks, ETFs, and their options commission-free!

About IPIX

Innovation Pharmaceuticals, Inc. is a clinical stage biotechnology company, which engages in the development of therapies with anti-infective, oncology, anti-inflammatory, and dermatology applications. It focuses on its antifungal drug candidate called Brilacidin. 

CEO
Leo Ehrlich
CEOLeo Ehrlich
Employees
4
Employees4
Headquarters
Wakefield, Massachusetts
HeadquartersWakefield, Massachusetts
Founded
2007
Founded2007
Employees
4
Employees4

IPIX Key Statistics

Market cap
214.91K
Market cap214.91K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
75.71K
Average volume75.71K
High today
$0.0004
High today$0.0004
Low today
$0.0004
Low today$0.0004
Open price
$0.0004
Open price$0.0004
Volume
6.48K
Volume6.48K
52 Week high
$0.0186
52 Week high$0.0186
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

With a market cap of 214.91K, Innovation Pharmaceuticals(IPIX) trades at $0.00.

On 2026-03-16, Innovation Pharmaceuticals(IPIX) stock traded between a low of $0.00 and a high of $0.00. Shares are currently priced at $0.00, which is 0.0% above the low and 0.0% below the high.

The Innovation Pharmaceuticals(IPIX)'s current trading volume is 6.48K, compared to an average daily volume of 75.71K.

In the last year, Innovation Pharmaceuticals(IPIX) shares hit a 52-week high of $0.02 and a 52-week low of $0.00.

In the last year, Innovation Pharmaceuticals(IPIX) shares hit a 52-week high of $0.02 and a 52-week low of $0.00.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.